Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
about
Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pioglitazone Prevents Stroke i ...... ce Intervention After Stroke).
@en
Pioglitazone Prevents Stroke i ...... ary Analysis of the IRIS Trial
@nl
type
label
Pioglitazone Prevents Stroke i ...... ce Intervention After Stroke).
@en
Pioglitazone Prevents Stroke i ...... ary Analysis of the IRIS Trial
@nl
prefLabel
Pioglitazone Prevents Stroke i ...... ce Intervention After Stroke).
@en
Pioglitazone Prevents Stroke i ...... ary Analysis of the IRIS Trial
@nl
P2093
P1433
P1476
Pioglitazone Prevents Stroke i ...... nce Intervention After Stroke)
@en
P2093
Anne M Lovejoy
Catherine M Viscoli
Hooman Kamel
IRIS Trial Investigators
Karen L Furie
Lawrence H Young
Mark Gorman
Robin Conwit
Scott E Kasner
Shadi Yaghi
P304
P356
10.1161/CIRCULATIONAHA.117.030458
P407
P577
2017-10-30T00:00:00Z